SEC Form 4 · accession 0001562180-19-000166
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan P Stimson
Officer — Chief Strategy Officer
Period of report
Dec 31, 2018
Accepted (ET)
Jan 3, 2019 · 8:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 31, 2018 | M | 5,000 | $1.20 | A | 41,703 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $1.20 | Dec 31, 2018 | M | 5,000 | D | — | Apr 22, 2023 | Common Stock | 5,000 | 5,938 | D |
Explanation of responses
- F1Includes 8,033 Restricted Stock Units.
- F2The shares subject to the option vest monthly over four years commencing April 23, 2013.